ARGX Q2 2023 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena

ARGXargenx SE

$46B

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$468M+320.5% YoY

Gross Profit

$107M22.9% margin

Operating Income

-$189M-40.3% margin

Net Income

-$113M-24.1% margin

EPS (Diluted)

$-2.03

QoQ Revenue Growth

+281.5%

Cash Flow

Operating Cash Flow

-$258M

Free Cash Flow

-$262M

Stock-Based Comp.

$94M

Balance Sheet

Total Assets

$3.2B

Total Liabilities

$336M

Stockholders' Equity

$2.9B

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$468M	$111M	+320.5%
Gross Profit	$107M	-$169M	+163.6%
Operating Income	-$189M	-$379M	+50.3%
Net Income	-$113M	-$416M	+72.9%

Geographic Segments

United States

$441M90%

Japan

$24M5%

EMEA

$23M5%